A Phone App to Help Cut Salt in Type 2 Diabetes and Kidney Disease
Tests a diet education app in adults with type 2 diabetes and kidney disease.
Plain-language title generated from the registry record
Registry title: Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Key facts
- Where
- Herlev and Hillerød, DenmarkSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 74 years old?
Source: NCT07485075, who can take part
Where in Denmark
- Steno Diabetes Center CopenhagenHerlev, DenmarkTaking people
- Nordsjællands Hospital HillerødHillerød, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Steno Diabetes Center Copenhagen
- Trial code
- NCT07485075
- Record updated
- 20 March 2026
- Original description
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).Read full original descriptionShow less
SBI 2024-2026 STENO FOOD CONCEPT
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
Inclusion: Type 2 diabetes (ICD-10 DE11.x); Age 18-74 years; BMI < 35 kg/m²; eGFR 30-59 ml/min and UACR > 30 mg/g; Stable medication for ≥3 months; Ability to read and understand Danish.
Exclusion: Type 1 diabetes or other diabetes types; Active cancer; Short bowel syndrome or celiac disease; Use of sodium chloride tablets; Current vegan diet; No access to digital platform (intervention group only).